Four small firms hit as US FDA takes a new step in war on unauthorised vapes

The US Food and Drug Administration (FDA) has for the first time filed civil money penalty (CMP) complaints against four small vaping companies for manufacturing and selling e-liquids without marketing authorisation.

The CMPs, which the FDA has authority to assess for violations of the Food, Drug, and Cosmetic (FD&C) Act, carry a maximum penalty of $19,192 per violation. The complaints have been filed as part of what Brian King, director of the FDA’s Center for Tobacco Products (CTP) described as “a comprehensive approach to actively identify violations actively and to deter illegal conduct”.